Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Leaders in Pharmaceutical Business Intelligence announce their latest addition to the BioMed e-Series ebooks: Genomics Orientations for Individualized Medicine, Volume One.

This e-book is a comprehensive review of Genomics Orientations to Personalized Medicine, latest discoveries in Genomics, and related opportunities for Targeted Therapy written by Experts, Authors, and Writers and can be previewed at http://pharmaceuticalintelligence.com/biomed-e-books/genomics-orientations-for-personalized-medicine/volume-one-genomics-orientations-for-personalized-medicine/.

Leaders in Pharmaceutical Business Intelligence is a scientific, medical and business multi-expert authoring environment in several domains of life sciences, pharmaceutical, healthcare & medical industries. The venture operates as an online scientific intellectual exchange at their website http://pharmaceuticalintelligence.com and for curation and reporting on frontiers in biomedical, biological sciences, healthcare economics, pharmacology, pharmaceutical & medicine. In addition the venture publishes a BioMedical E-book Series available on Amazon’s Kindle platform (future titles at http://pharmaceuticalintelligence.com/biomed-e-books/).

As drug discovery and medical information moves to an open-access, open-innovation platform, medical researchers and professionals are recognizing the need to converse with each other, in real-time, on the impact new discoveries may have on their research and clinical practice.

Open-access and open=innovation require a people-based strategy, having expertise in a diverse and cross-integrative number of medical topics to provide the in-depth understanding of the current research and challenges in each field as well as providing a more conceptual-based search platform. To address this need, human intermediaries, known as scientific curators, are needed to narrow down the information and provide critical context and analysis of medical and scientific information in an interactive manner powered by web 2.0. This curation offers better organization and visibility to the critical information useful for the next innovations in academic, clinical, and industrial research by providing these hybrid networks.

We are addressing the need to organize the massive amount of scientific information by:

• delivering curation and summary interpretations of latest findings and innovations on an open-access, Web 2.0 platform with future goals of providing primarily concept-driven search
• providing a social platform for scientists and clinicians to enter into discussion using social media
• compiling recent discoveries and issues in yearly-updated BioMedical E-book Series on Amazon’s mobile Kindle platform.

The e-book is divided into the following Parts, subdivided into 20 Chapters and includes an Introduction and Epilogue:

PART I. The Classical Model of the Gene

PART II. Emergence of the Genomic Network

PART III. Genomics Enters the Clinic

PART IV. Targeting Cancer

PART V.   Systemic and Organ System Genomics